Drosophila study maps dual role of Xrp1 in DNA damage response and cell competition downstream of p53

Research in PLOS Genetics identifies Xrp1 as a mediator of both p53-dependent DNA damage signalling and a separate p53-independent cell-competition mechanism, offering a model for understanding p53 tumour suppression in mammals.

Published · AI-drafted summary based on 1 public source
Illustration for generic story
Illustrative image — not from the source article.
Share

A study published in PLOS Genetics (DOI: 10.1371/journal.pgen.1012309) by Chaitali Khan, Nasser M. Rusan, and Nicholas E. Baker reports that the bZip AT-hook transcription factor Xrp1 carries out at least two distinct genome-protective functions in Drosophila.

First, Xrp1 acts as a transcriptional effector of p53, mediating p53-dependent gene expression and DNA damage-induced apoptosis as part of the DNA damage response (DDR). This places Xrp1 directly downstream of the fly's primary tumour-suppressor pathway. Second, the study describes a p53-independent role for Xrp1 in cell competition — a quality-control process by which less-fit cells are eliminated from a tissue by their neighbours. The two functions are separable, suggesting Xrp1 integrates multiple genome-integrity mechanisms.

Because Drosophila p53 biology is considered a tractable model for understanding how the mammalian p53 pathway suppresses tumourigenesis, these findings may inform research into how p53 coordinates apoptosis, cell competition, and genome stability in human cells. The work is of primary relevance to basic research in cancer biology, developmental genetics, and model-organism genomics.

Sources

Read the original reporting — these are the public sources this summary draws from.

  1. Primary source PLOS Genetics · 2026-09-18
    Dual contributions of Xrp1 to genome integrity through the DNA damage response and cell competition

Tags

xrp1 p53 dna-damage-response cell-competition drosophila apoptosis tumour-suppression cancer-biology
Share

About Genetic Current

Educational summaries of public genetics news

Genetic Current is the news section of Evagene, an academic, research, and educational pedigree-modelling platform. Stories are AI-drafted summaries of items from trusted public sources, written for researchers, clinicians, educators, students, genealogists, and patients with an interest in genetics. Summaries are for educational and research purposes only and are not medical advice.

Join the Evagene Alpha Waiting List